Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.02 USD | +1.97% | -4.14% | -6.10% |
04-17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
04-17 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.10% | 2.39B | |
+2.56% | 42.75B | |
+47.70% | 41.61B | |
+11.97% | 41.34B | |
-8.83% | 26.59B | |
+7.11% | 25.49B | |
-22.84% | 18.12B | |
+30.59% | 12.24B | |
-2.05% | 11.76B | |
+9.15% | 11B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Celldex Therapeutics : Jefferies & Co Reinstates Coverage on Celldex Therapeutics With Buy Rating, $66 Price Target